Abstract
Alzheimer's disease (AD), one of the major causes of disability and mortality in Western societies, is a progressive age-related neurodegenerative disorder. Increasing evidence suggests that the etiology of AD may involve disruptions of zinc (Zn) homeostasis. This review discusses current evidence supporting a potential role of Zn and zinc transporters (ZnTs) in processing of the amyloid beta protein precursor (APP) and amyloid beta (Aβ) peptide generation and aggregation.
Original language | English |
---|---|
Pages (from-to) | 98-106 |
Number of pages | 9 |
Journal | BioFactors |
Volume | 38 |
Issue number | 2 |
DOIs | |
State | Published - Mar 2012 |
Keywords
- Alzheimer's disease
- Amyloid beta peptide
- Mild clinical impairment
- Preclinical Alzheimer's disease
- Zinc
- Zinc transporter proteins
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Clinical Biochemistry